Efficacy of metronomic chemotherapy in recurrent cervical cancer
INTRODUCTION: Cervical cancer (CC) accounts for approximately 2.1% of all new malignant neoplasms and 2.6% of cancer-related deaths among women in Poland. Despite preventive measures, advanced or recurrent CC remains a therapeutic challenge, with median overall survival below 12 months in most cases...
Wedi'i Gadw mewn:
| Prif Awduron: | , , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Via Medica
2026-04-01
|
| Cyfres: | Oncology in Clinical Practice |
| Pynciau: | |
| Mynediad Ar-lein: | https://journals.viamedica.pl/oncology_in_clinical_practice/article/view/111569 |
| Tagiau: |
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|